[REVISION HISTORY]
Colorectal cancer surveillance and management updates
Updated 1 time since CLSTR started tracking revisions of this situation.
What changed
2026-09-22 07:01 UTC → 2026-09-25 14:58 UTC ·
added
removed
Recent medical research and updated clinical guidelines are reshaping the management and surveillance protocols for colorectal cancer risks. The European Polyp Surveillance Trial (EPoS), involving 10,799 patients across eight European countries, suggests that delaying the first surveillance colonoscopy by three to five years following the removal of advanced adenomas does not increase the risk of colorectal cancer development or mortality. This finding addresses the significant burden Findings published in The New England Journal of Medicine indicate that frequent extending the interval to the five-year mark does not significantly increase the risk of developing colorectal cancer or dying from the disease compared to a three-year interval. This research provides new data for clinical guidelines regarding follow-up procedures place on frequency for patients and healthcare systems. at higher risk of developing new lesions. In addition to these findings, the American College of Gastroenterology (ACG) has released new evidence-based guidelines regarding hereditary adenomatous polyposis syndromes. These guidelines focus on improving the identification, diagnosis, and management of syndromes caused by germline variants in genes such as APC or AXIN2 through enhanced risk assessment, genetic testing, and timely surgical or endoscopic intervention.
Versions
- 2026-09-25 14:58 UTC Colorectal cancer surveillance and management updates
- 2026-09-22 07:01 UTC Colorectal cancer surveillance and management updates
Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.